Exabis Library
Welcome to the e-CCO Library!
P535: The use of therapeutic drug monitoring for infliximab and adalimumab in inflammatory bowel disease: Practice patterns, understanding and interpretation
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P536 Early prediction of intravenous corticosteroid therapy failure in moderate–severe ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P536: Combination therapy of bone marrow mesenchymal stromal cells and azathioprine not affect the clinical course luminal Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P536: Comparison of outcomes of infliximab biosimilar CT-P13 with infliximab originator in patients with inflammatory bowel disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P536: Effectiveness, safety and persistence of treatment with ustekinumab in a cohort of patients with moderate-to-severe refractory Crohn's Disease.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P536: Is there any association between fat body mass and bone mineral density in patients with Inflammatory Bowel Disease?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P536: Minimally invasive gasless technique for ileocolic resection using an existing McBurney incision
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P536: Thiopurine metabolite levels in pregnant IBD patients and infants following intrauterine thiopurine exposure
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P537 Real-world long-term effectiveness of ustekinumab in Crohn’s disease: Results from the ENEIDA registry
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P537: Adalimumab: Relevance of drug trough levels and antibodies assessment in the prognosis of Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P537: Anemia in Crohn's Disease: Response to treatment and risk of recurrence
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P537: Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P537: Prevalence of post-COVID-19 vaccination IBD flare-ups: a single-center prospective study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P537: Steroid use in patients with immune checkpoint inhibitor colitis
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P537: The impact of early disease control with vedolizumab on surgery rates among patients with Crohn’s disease: a post-hoc analysis of the GEMINI trials
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P538 Pregnancy outcomes in women with psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis treated with ustekinumab
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P538: Can enteral polymeric diet change the post-surgical outcome in Crohn's disease patients? A pilot study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P538: Enteral nutrition for the maintenance of remission in adults with inactive Crohn’s disease: A meta-analysis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P538: Implementation of Kono-S anastomosis as a new standard of surgical care
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P538: Suboptimal disease control is common in patients with Crohn's perianal fistulas with capacity to optimise medical and surgical treatment in real-world experience: A cross-sectional analysis of baseline disease characteristics in the FINESS study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM